oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha-1 adrenergic cardura drug blocker which inhibits the binding of norepinephrine to alpha receptors in cardura drug autonomic nervous system. The primary effect of this blockage is relaxed vascular smooth muscle tone.

decreases peripheral vascular resistance, leading to decreased blood pressure. DoxazosinFrom Wikipedia, the free encyclopedia(Redirected from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC cardura drug C02CA04PubChem 3157DrugBank cardura drug dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 cardura drug ?Therapeutic considerationsPregnancy cat. ?Legal cardura drug ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous system. The primary effect of cardura drug blockage is cardura drug vascular smooth muscle tone (vasodilation), which decreases peripheral vascular.

to decreased blood pressure. DoxazosinFrom Wikipedia, the free encyclopedia(Redirected from Cardura)Jump to: navigation.